• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • 2018 Great Debate examines questions about hydroxychloroquine dosing guidelines

    2018 Great Debate examines questions about hydroxychloroquine dosing guidelines

    October 22, 2018

    Rheumatologists know HCQ as the single most useful agent for lupus, and ophthalmologists know HCQ as a preventable cause of retinopathy that can result in blindness. Ophthalmologists, not rheumatologists, published the latest guidelines.

  • Treat-to-target strategy helps halt progression, sustain remission

    Treat-to-target strategy helps halt progression, sustain remission

    October 22, 2018

    During Monday’s Paul Klemperer, MD Memorial Lecture, Josef S. Smolen, MD, discussed the pathways to joint destruction in RA and reviewed evidence supporting the relationship between clinical disease activity and progression of articular damage.

  • Filgotinib shows promise in treating psoriatic arthritis

    Filgotinib shows promise in treating psoriatic arthritis

    October 22, 2018

    Filgotinib, an oral selective Janus kinase 1b(JAK1) inhibitor, showed positive results in a phase II placebo-controlled study for active psoriatic arthritis (PsA).

  • Research sheds new light on celiac disease relationship to autoimmune diseases

    Research sheds new light on celiac disease relationship to autoimmune diseases

    October 22, 2018

    Celiac disease is a unique model of autoimmune disease. It’s the only autoimmune disease for which the trigger is known.

  • Rarity of scleroderma makes evidence-based research into non-pharmaceutical interventions difficult

    Rarity of scleroderma makes evidence-based research into non-pharmaceutical interventions difficult

    October 22, 2018

    More research is needed using multisite, different research designs, and involvement of people with scleroderma to determine evidence-based non-pharmaceutical interventions for scleroderma, according to this year’s ARHP Distinguished Lecturer.

  • Obesity should be part of primary intervention for OA and OP patients

    Obesity should be part of primary intervention for OA and OP patients

    October 22, 2018

    The central role of the adipocyte in the pathogenesis and treatment of osteoporosis was the focus of this year’s Oscar S. Gluck, MD Memorial Lecture by Clifford J. Rosen, MD.

  • Studies result in new, updated FDA safety warnings

    Studies result in new, updated FDA safety warnings

    October 22, 2018

    Rachel L. Glaser, MD, Clinical Team Leader, Division of Pulmonary, Allergy, and Rheumatology Products for the FDA, reviewed the results from the PRECISION trial and other studies impacting rheumatology.

  • UW’s Neutrophil NETs win 2018 Knowledge Bowl

    UW’s Neutrophil NETs win 2018 Knowledge Bowl

    October 22, 2018

    The team of Jean Liew, MD, Joanna Marco, MD, and Grant Hughes, MD, from the Univeristy of Washington held off the Cuse Crusaders and defending champion House of DMARDs on Monday.

  • Latest research into innate immune system disorders is changing thinking about autoinflammatory diseases

    Latest research into innate immune system disorders is changing thinking about autoinflammatory diseases

    October 22, 2018

    Research on a range of inflammatory conditions has led to insights with far reaching practical implications that are changing the way rheumatologists think about autoinflammatory diseases.

  • AMP research projects offer new insights in single-cell technology

    AMP research projects offer new insights in single-cell technology

    October 22, 2018

    The Accelerating Medicines Partnership (AMP) is beginning to see early data from its network of investigators working in rheumatology. Some of that early data will be shared at an ACR Basic Science track session on Tuesday.

1 2 3
Next Page

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy